Company Filing History:
Years Active: 1996-1999
Title: The Innovative Contributions of Keith S. Lienhop
Introduction
Keith S. Lienhop is a notable inventor based in St. Charles, Missouri, with a remarkable portfolio of five patents. His work primarily focuses on pharmaceutical innovations that enhance drug delivery systems and improve patient outcomes. Lienhop's inventions reflect a deep understanding of both chemistry and the needs of the medical field.
Latest Patents
Among his latest patents is a "Long Acting GI and Esophageal Protectant," which describes a bioadherent, orally ingestible system. This system comprises a water-in-oil emulsion with two distinct phases. One phase consists of approximately 75% to 99% by volume of an internal hydrophilic phase, while the other phase contains about 25% to 1% by volume of an external hydrophobic phase. The external hydrophobic phase includes two components: a hydrophobic oil and an emulsifier with a low HLB value. Another significant patent is the "Tastemasked Liquid Pharmaceutical Delivery System," which is designed to be a substantially tasteless liquid containing an active material. This system includes a high osmolarity aqueous solution with specific proportions of water, sugar derivatives, hydrogenated maltose syrup, and polyhydroxy alcohol.
Career Highlights
Keith S. Lienhop has worked with prominent companies in the pharmaceutical industry, including K.V. Pharmaceutical Company and Kv Pharmaceuticals Company. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.
Collaborations
Throughout his career, Lienhop has collaborated with notable professionals, including Robert C. Cuca and R. Saul Levinson. These collaborations have likely enriched his work and led to advancements in his inventions.
Conclusion
Keith S. Lienhop's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of effective drug delivery systems that benefit patients worldwide.